Lyell Immunopharma, Inc. (LYEL)
NASDAQ·Healthcare·Biotechnology
$10.09
+8.38%
Mkt Cap $279.31M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (9 analysts)
$42.67
Range $34.00 – $49.00
Implied Upside
+322.9%
Consensus $42.67 vs current $10.09
NASDAQ·Healthcare·Biotechnology
$10.09
+8.38%
Mkt Cap $279.31M
Buy
2
Hold
0
Sell
0
Price Target (9 analysts)
$42.67
Range $34.00 – $49.00
+322.9%
Consensus $42.67 vs current $10.09